Milestone Scientific Inc (NYSEAMERICAN:MLSS) reported results of a detailed survey involving Board Certified Anesthesiologists in the US, in order to better understand anesthesiology and where its practitioners believe the profession should go in the future.
The company noted that the survey was conducted on its behalf by research firm Schlesinger Group, revealing perceptions and attitudes of the medical profession, with the majority of the anesthesiologists surveyed saying they are seeking innovation and change.
“As we strive to become the new standard of care in epidural procedures, it is important to understand the environment the anesthesiology profession is facing. I am pleased to have had the opportunity to conduct this research study with Schlesinger Group, which highlights the needs of practice Anesthesiologists, their concerns regarding optimal epidural placement, as well as opportunities and challenges for the future,” said Milestone Scientific President Arjan Haverhals in a statement.
READ: Milestone Scientific, the pressure sensing specialist, has cash in bank and eyeing growing dental sales
He added: “Based on the findings of the research, we believe that the CompuFlo Epidural System directly addresses many of these key challenges.”
Milestone Scientific said it believes the survey highlights the need for technological innovations in the field of anesthesia, most notably in patients having epidural analgesia during labor and delivery.
Highlights of the survey include:
- 56% of Anesthesiologists feel the pressure of time, impacting patient care
- 84% of Anesthesiologists believe their "skill and acumen are not fully leveraged"
- Only 16% of anesthesiologists believe the field is headed in a positive direction
- 70% believe hospital procurement holds the field back from access to innovative technologies
- 96% say they must embrace new technologies
Investors interested in a more in-depth look at the data, the motivation behind the survey, and how Milestone Scientific plans to move the field of anesthesiology into the future by addressing the call for innovation and change are invited to join a webinar to be hosted on Tuesday, January 12 at 9:00 AM EST.
To register for the webinar event, visit https://bit.ly/milestonewebinar
Milestone Scientific is a medical device research and development (R&D) group that has developed its CompuFlo Epidural Instrument for epidural injections, which has a 99% success in locating the epidural space on the first attempt.
The company said clinical and safety benefits of CompuFlo are backed by extensive published clinical data, demonstrating significant reductions in dural punctures, as well as complication rates, contributing to a significant savings of time on the part of anesthesiologists as well as having the potential to significantly reduce costs associated with morbidity.
Contact Sean at sean@proactiveinvestors.com